Selecting the Right Delivery System for Subcutaneous Injection

Printer-friendly version

What is the peak dosing volume for a drug designed to be delivered via a bolus subcutaneous injection? At one time, the answer would have been a straightforward “up to 1 mL.” That answer however is fast on its way to redundancy. The rise of viscous biologic drugs, the shift toward patient self-injection, and the emergence of safer, simpler, and more convenient devices are all contributing to the expansion of what is possible for subcutaneous administration. The positive impact these converging market trends will have on healthcare productivity, therapy adherence, and brand differentiation is enormous. - See more on this online article at Drug Development and Delivery magazine. Click here: